Form 4: AEHR VP Sells 3,000 Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Aehr Test Systems' VP of Contactor Business Unit, Alistair N Sporck, sold 3,000 shares of common stock for approximately $82,749 as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Alistair N Sporck, VP Contactor Business Unit at Aehr Test Systems, sold a total of 3,000 shares of common stock.
  • The sales occurred on February 9, 2026, in two separate transactions.
  • 2,700 shares were sold at a price of $27.57 per share.
  • An additional 300 shares were sold at a price of $27.59 per share.
  • The total proceeds from these sales amount to approximately $82,749.
  • Following these transactions, Sporck directly beneficially owns 25,153 shares of common stock, which includes shares subject to unvested restricted stock units.
  • Sporck also indirectly owns 5,214 shares through a trust.
  • The transactions were executed pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event because the sale was executed under a pre-arranged Rule 10b5-1 plan, which typically indicates a planned financial management strategy rather than a reaction to new, undisclosed information.

Positives

  • The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned sale rather than an immediate reaction to new information.

Negatives

  • An insider sale, even under a 10b5-1 plan, can sometimes be perceived as a lack of conviction in the company's near-term stock price appreciation.
  • The sale reduces the direct beneficial ownership of a key executive.

Industry Context

StockSavvy.ai notes that insider sales, particularly those executed under a Rule 10b5-1 plan, are common for executives managing personal finances and diversifying portfolios. While a sale might be viewed cautiously, the pre-planned nature often mitigates concerns about immediate negative signals, differentiating it from opportunistic selling.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney GrantAlistair N Sporck granted a Power of Attorney to Gayn Erickson, Chris Siu, Adil Engineer, and Vernon Rogers to execute and file Forms 3, 4, and 5 on his behalf.2023-06-02Streamlines compliance with Section 16 reporting requirements for the reporting person.

Related Party Transactions

  • The sale of 3,000 shares of common stock by Alistair N Sporck, a Vice President of Aehr Test Systems, constitutes a related party transaction due to his insider status.

Stakeholder Impact

  • Shareholders may view the insider sale as a minor signal, though the pre-arranged 10b5-1 plan mitigates concerns about immediate negative implications. The reduction in direct executive ownership could be perceived as a slight decrease in alignment with shareholder interests.

Key Dates

DateDescription
2023-06-02Execution date of the Power of Attorney by Alistair N Sporck.
2026-02-09Date of common stock sales by Alistair N Sporck.
2026-02-10Date of Form 4 filing.

Recommendation

hold

The insider sale by a VP, while reducing direct ownership, was executed under a pre-arranged Rule 10b5-1 plan. This suggests a planned financial move rather than a reaction to new, adverse company-specific information. Therefore, it does not provide a strong signal for a 'buy' or 'sell' recommendation, warranting a 'hold' position based solely on this filing.

Keywords

Aehr Test Systems, AEHR, Insider Sale, Form 4, Alistair N Sporck, Stock Transaction, Rule 10b5-1, Common Stock, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.